Welcome to our dedicated page for Crescent Capital Bdc SEC filings (Ticker: CCAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Crescent Capital BDC, Inc. (NASDAQ: CCAP) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered tools to help interpret them. As a Maryland-incorporated business development company regulated under the Investment Company Act of 1940 and listed on Nasdaq, Crescent Capital BDC files a range of documents that explain its portfolio, leverage, and governance.
Key filings for CCAP include annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide detailed information on investment income, net investment income, portfolio composition by asset type, fair value of investments, leverage, and risk factors. These reports describe the mix of senior secured first lien loans, unitranche first lien loans, second lien loans, unsecured debt, equity investments, and LLC/LP equity interests, as well as the number of portfolio companies and sector diversification.
Crescent Capital BDC also files current reports on Form 8-K to disclose material events. Recent 8-K filings have covered items such as quarterly earnings press releases and the entry into a Fourth Supplement to its Master Note Purchase Agreement governing the issuance of additional senior unsecured notes. These documents outline terms such as fixed interest rates, maturities, and intended use of proceeds to repay certain indebtedness and for general corporate purposes.
In addition, CCAP maintains exchange listings for its common stock on Nasdaq and its 5.00% Notes due 2026 on the New York Stock Exchange under the symbol FCRX, as reflected in its registration information. On this page, AI-generated summaries highlight the main points of lengthy filings, helping users quickly understand leverage covenants, asset coverage requirements, and other regulatory conditions that apply to Crescent Capital BDC. Real-time updates from EDGAR ensure that new Forms 10-K, 10-Q, 8-K, and other disclosures, as well as information on registered debt securities, are accessible with concise explanations.
Crescent Capital BDC, Inc. has issued two new series of senior unsecured notes and arranged a third under a note purchase supplement. The supplement covers up to $67.5 million of Tranche A notes due February 13, 2029, $67.5 million of Tranche B notes due February 13, 2031, and $50.0 million of Tranche C notes due May 22, 2029.
The Tranche A notes carry a fixed rate of 5.87% and the Tranche B notes a fixed rate of 6.20%. The Tranche A and Tranche B notes were issued on February 13, 2026, while issuance of the Tranche C notes is expected on May 22, 2026, subject to customary closing conditions.
To manage interest exposure, the company entered into interest rate swaps on each of Tranche A and Tranche B for notional amounts of $67.5 million. For Tranche A it will receive fixed 5.87% and pay three month term SOFR plus 2.5325% through February 13, 2029. For Tranche B it will receive fixed 6.20% and pay three month term SOFR plus 2.8050% through February 13, 2031.
Crescent Capital BDC (CCAP) provides a detailed look at its investment portfolio, which is heavily focused on privately negotiated debt across U.S. and international middle‑market companies. The schedule lists numerous unitranche, senior secured first lien, and second lien term loans and revolvers.
Borrowers span sectors such as health care services, software and IT, insurance, consumer services, commercial and professional services, industrials, and financials, with selected exposure in Europe and Australia. Most instruments reference floating base rates with contractual spreads and, in many cases, PIK (payment‑in‑kind) components, and have maturities extending broadly from 2025 into the early 2030s.
The portfolio also includes delayed draw term loans, unsecured PIK debt, foreign currency exchange contracts with Wells Fargo Bank, and a range of equity positions and partnership interests, giving CCAP a mix of income‑generating loans and potential equity upside.
Crescent Capital BDC, Inc. reported lower results for the year ended December 31, 2025, with net investment income of $1.81 per share and net income of $0.93 per share, down from $2.40 and $1.99 per share in 2024. Investment income fell to $167.3 million from $197.4 million, mainly because benchmark interest rates declined and certain debt investments were restructured. Net asset value per share declined to $19.10 from $19.98 as credit marks and foreign currency hedges weighed on results. For the fourth quarter of 2025, net investment income was $0.45 per share and net income was $0.23 per share. The company’s board declared a regular cash dividend of $0.42 per share for the first quarter of 2026, payable April 15, 2026 to shareholders of record on March 31, 2026. At year-end, Crescent BDC held $1.57 billion of investments across 184 portfolio companies, a weighted average yield on income-producing securities of 10.0%, and a debt-to-equity ratio of 1.25x, supported by $31.5 million of cash and $242.0 million of undrawn credit capacity.
Texas County & District Retirement System reports a significant passive stake in Crescent Capital BDC, Inc. It beneficially owns 5,001,752 shares of common stock, representing 13.50% of the class as of 12/31/2025.
The fund has sole power to vote and dispose of all 5,001,752 shares, with no shared voting or dispositive power. It certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Crescent Capital BDC.
Crescent Capital BDC, Inc. (CCAP) reported an insider share purchase by its Chief Financial Officer on a Form 4. On 11/17/2025, the CFO bought 2,000 shares of common stock in an open market transaction coded as a purchase.
The weighted average purchase price was $13.3415 per share, with individual trades executed between $13.34 and $13.3499. After this transaction, the CFO beneficially owned 34,284 shares of CCAP common stock.
This total includes 2,627 shares acquired during 2025 through dividend reinvestment that had not been previously reported. The filing notes that full trade price details are available to regulators, the company, or any security holder upon request.
Crescent Capital BDC, Inc. filed an 8-K to report that it issued a press release with its financial results for the quarter ended September 30, 2025. The company furnished the full text of this earnings press release as Exhibit 99.1. The information in this section, including the exhibit, is being treated as furnished rather than filed under securities law, which affects how it is incorporated into other regulatory documents.
Crescent Capital BDC (CCAP) filed a 10-Q outlining a broad portfolio of mainly floating-rate private credit investments. The schedule lists numerous first-lien unitranche and senior secured loans, alongside revolvers and a handful of equity positions across software, healthcare, insurance, logistics, and consumer services.
Terms are predominantly benchmark-based with floors and occasional PIK features. Examples include Patriot Growth Insurance Services, LLC unitranche first-lien term loans at S + 500 with a 75 floor maturing 10/2028; Ingenio, LLC unitranche first-lien term loan at S + 800 (600 PIK), 100 floor maturing 08/2027; and Seko Global Logistics Network, LLC senior secured first-lien term loan at S + 800 maturing 05/2030. The portfolio also references facilities tied to SOFR, SONIA, EURIBOR, SARON, and BBSY, with maturities spanning 2025 through 2031, and select equity holdings such as Park Place Technologies and Odessa Technologies.
Crescent Capital BDC, Inc. entered into a Fourth Supplement to its Note Purchase Agreement to issue senior unsecured notes in three tranches: up to $67.5 million Tranche A at 5.87% due February 13, 2029; up to $67.5 million Tranche B at 6.20% due February 13, 2031; and $50.0 million Tranche C at 5.97% due May 22, 2029.
Interest is payable semiannually on February 13 and August 13, starting February 13, 2026. Issuances will occur in two closings on or before May 22, 2026, with Tranches A and B expected on or before February 16, 2026 and Tranche C on May 22, 2026, subject to customary closing conditions. The notes are general unsecured obligations ranking pari passu with other unsecured unsubordinated debt and include a change of control offer to repay at par. The company intends to use net proceeds to repay certain indebtedness and for general corporate purposes, with potential re-borrowing under its debt facilities.
Crescent Capital BDC insider purchase: On 08/28/2025, reporting person Kirill Bouek, an officer and controller of Crescent Capital BDC, Inc. (CCAP), purchased 200 shares of the company’s common stock at $15.6666 per share. After the transaction, Bouek beneficially owned 1,057 shares, which includes 64 shares acquired earlier in 2025 through dividend reinvestment and not previously reported. The Form 4 was filed on 08/29/2025 and signed by George P. Hawley as attorney-in-fact. The filing is a routine Section 16 disclosure showing a small insider purchase and updated beneficial ownership.
Raymond Barrios, a Managing Director and officer of Crescent Capital BDC, Inc. (CCAP), reported insider purchases on 08/25/2025. The filing shows two separate non-derivative acquisitions of common stock: 2,230 shares at $15.6316 and 1,015 shares at $15.62, both marked with transaction code P (pursuant to a written plan). After these transactions Barrios beneficially owned 19,177 shares directly. The report also notes 1,181 shares acquired through dividend reinvestment in 2025 that were not previously reported under Rule 16a-11. The Form 4 was signed by an attorney-in-fact on 08/26/2025.